Virginia Retirement Systems’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.56M Sell
15,350
-10,850
-41% -$871K 0.01% 469
2025
Q3
$1.43M Sell
26,200
-8,700
-25% -$435K 0.01% 492
2025
Q2
$1.85M Buy
+34,900
New +$1.77M 0.01% 422
2019
Q3
Sell
-6,600
Closed -$779K 1135
2019
Q2
$779K Sell
6,600
-9,000
-58% -$907K 0.01% 758
2019
Q1
$1.35M Buy
15,600
+6,100
+64% +$519K 0.02% 558
2018
Q4
$599K Sell
9,500
-2,800
-23% -$192K 0.01% 821
2018
Q3
$971K Sell
12,300
-8,800
-42% -$574K 0.01% 721
2018
Q2
$1.26M Buy
21,100
+200
+1% +$10.8K 0.02% 615
2018
Q1
$843K Buy
+20,900
New +$1.02M 0.01% 699
2017
Q4
Sell
-28,100
Closed -$1.32M 1003
2017
Q3
$1.32M Buy
+28,100
New +$1.13M 0.02% 593
2017
Q1
Sell
-25,200
Closed -$337K 1133
2016
Q4
$337K Buy
+25,200
New +$407K ﹤0.01% 841

Other funds holding EXAS

Virginia Retirement Systems's EXAS Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Exact Sciences (EXAS) stake by 41% in Q4 2025, selling an estimated $871K and leaving 15,350 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #469.

Virginia Retirement Systems first reported a position in EXAS in Q4 2016 and has held it in 11 quarters since. The position peaked at $1.85M in Q2 2025. 709 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Virginia Retirement Systems held 15,350 shares of Exact Sciences worth $1.56M as of Q4 2025.
  • Virginia Retirement Systems sold 10,850 Exact Sciences shares in Q4 2025, an estimated $871K.
  • Exact Sciences made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #469 holding.
  • Virginia Retirement Systems first reported a position in Exact Sciences in Q4 2016 and has held it in 11 quarters since.
  • Virginia Retirement Systems's Exact Sciences position peaked at $1.85M in Q2 2025.
  • 709 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.